English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Background  Previous Positron Emission Tomography (PET) studies of 5-HT 1A  receptors have shown an influence of several genetic factors, including the triallelic serotonin transporter gene-linked polymorphic region on the binding potential (BP ND ) of these receptors. The aim of our study was to investigate the relationship between a 5-HT 1A  promoter polymorphism and the binding potential of another selective 5-HT 1A  receptor antagonist, [ 18 F]MPPF, in healthy subjects.    Methods  Thirty-five volunteers, including 23 women, underwent an [ 18 F]MPPF scan and were genotyped for both the C(-1019)G 5-HT 1A  promoter polymorphism and the triallelic serotonin transporter gene-linked polymorphic region. We used a simplified reference tissue model to generate parametric images of BP ND . Whole brain Statistical Parametric Mapping and raphe nuclei region of interest analyses were performed to look for an association of [ 18 F]MPPF BP ND  with the C(-1019)G 5-HT 1A  promoter polymorphism.    Results  Among the 35 subjects, 5-HT 1A  promoter genotypes occurred with the following frequencies: three G/G, twenty-one G/C, and eleven C/C. No difference of [ 18 F]MPPF BP ND  between groups was observed, except for two women who were homozygote carriers for the G allele and showed greater binding potential compared to other age-matched women over the frontal and temporal neocortex. However, the biological relevance of this result remains uncertain due to the very small number of subjects with a G/G genotype. These findings were not modified by excluding individuals carrying the S/S genotype of the serotonin transporter gene-linked polymorphic region.    Conclusions  We failed to observe an association between the C(-1019)G 5-HT 1A  promoter polymorphism and [ 18 F]MPPF binding in healthy subjects. However our data suggest that the small number of women homozygote for the G allele might have greater [ 18 F]MPPF BP ND  relative to other individuals. This finding should be confirmed in a larger sample.

5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study